Fig. 2From: The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysisNetwork diagram for success rate (a) and percentage change in inflammatory lesion count (b) at 12 weeks. AZA azelaic acid, bid twice daily, DOX doxycycline, IVE ivermectin, MET metronidazole, OD once daily. Note: network diagrams for other timepoints are available in the Additional file 1 Back to article page